MetaCap

Roivant Sciences Insider Trades

NASDAQ: ROIVHealth CareBiotechnology: Pharmaceutical PreparationsUSD

35.28+1.07 (+3.13%)

Market open · Delayed 15 min · as of Oct 9, 1:43 PM ET

Last 12 months

Purchases
0 · $0
Sales
39 · $250.04M
Shares bought / sold
0 / 7.19M
Net activity
Net selling $250.0 million

Roivant Sciences insider activity

Over the last 12 months, Roivant Sciences insiders reported 79 transactions on SEC Form 4: 0 open-market purchases and 39 sales. Insiders bought $0 and sold $250.0 million worth of stock, for net insider selling of $250.0 million. The largest seller was Sukhatme Mayukh, with $70.6 million in reported sales.

The most recent filing shows Epperly Melissa B, (Director) reporting a transaction in 17,750 shares at $4.46 on Oct 1, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put ROIV's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

ROIV insider transactions

Roivant Sciences insider transactions
DateInsiderTypeSharesValueFiling
Oct 1, 2026Epperly Melissa B,DirectorSale900$32.91KForm 4
Oct 1, 2026Epperly Melissa B,DirectorSale16,850$607.95KForm 4
Oct 1, 2026Epperly Melissa B,DirectorOption exercise17,750$79.17KForm 4
Sep 30, 2026Venker EricPresident & Immunovant CEOSale200,000$7.32MForm 4
Sep 30, 2026Venker EricPresident & Immunovant CEOOption exercise200,000$770.00KForm 4
Sep 30, 2026Gline MatthewCEOTax withholding76,171$2.79MForm 4
Sep 30, 2026Sukhatme MayukhPresident & CIOTax withholding46,879$1.71MForm 4
Sep 30, 2026Torti FrankPresident and Vant ChairTax withholding40,309$1.47MForm 4
Sep 20, 2026Pulik RichardCFOTax withholding2,129$84.67KForm 4
Sep 20, 2026Humes JenniferChief Accounting OfficerTax withholding3,880$154.31KForm 4
Sep 16, 2026Epperly Melissa B,DirectorAward5,054—Form 4
Sep 16, 2026Fitzgerald MeghanDirectorAward5,054—Form 4
Sep 16, 2026MOMTAZEE JAMES CDirectorAward5,054—Form 4
Sep 16, 2026MANCHESTER KEITH SDirectorAward5,054—Form 4
Sep 16, 2026Oren IlanDirectorAward5,054—Form 4
Sep 16, 2026Gold Daniel AllenDirectorAward5,054—Form 4
Sep 15, 2026Fitzgerald MeghanDirectorSale400$16.18KForm 4
Sep 15, 2026Fitzgerald MeghanDirectorSale4,712$186.97KForm 4
Sep 15, 2026Epperly Melissa B,DirectorSale600$24.23KForm 4
Sep 15, 2026Epperly Melissa B,DirectorSale4,338$172.00KForm 4
Sep 10, 2026Oren IlanDirectorTax withholding2,378$97.36KForm 4
Sep 10, 2026MOMTAZEE JAMES CDirectorTax withholding2,905$118.93KForm 4
Sep 10, 2026Fitzgerald MeghanDirectorTax withholding1,743$71.36KForm 4
Sep 10, 2026Epperly Melissa B,DirectorTax withholding2,179$89.21KForm 4
Sep 10, 2026Gold Daniel AllenDirectorTax withholding5,133$210.15KForm 4
Sep 8, 2026Fitzgerald MeghanDirectorSale20,000$798.00KForm 4
Sep 8, 2026Fitzgerald MeghanDirectorOption exercise20,000$176.00KForm 4
Aug 28, 2026Venker EricPresident & Immunovant CEOSale33,818$1.23MForm 4
Aug 28, 2026Venker EricPresident & Immunovant CEOSale166,182$5.92MForm 4
Aug 28, 2026Venker EricPresident & Immunovant CEOOption exercise200,000$770.00KForm 4
Aug 21, 2026Sukhatme MayukhPresident & CIOSale144,756$5.28MForm 4
Aug 21, 2026Sukhatme MayukhPresident & CIOOption exercise144,756$557.31KForm 4
Aug 20, 2026Sukhatme MayukhPresident & CIOSale17,519$653.46KForm 4
Aug 20, 2026Sukhatme MayukhPresident & CIOOption exercise17,519$67.45KForm 4
Aug 20, 2026Venker EricPresident & Immunovant CEOTax withholding13,909$512.41KForm 4
Aug 20, 2026Pulik RichardCFOTax withholding5,749$211.79KForm 4
Aug 19, 2026Sukhatme MayukhPresident & CIOSale172,899$6.43MForm 4
Aug 19, 2026Sukhatme MayukhPresident & CIOOption exercise172,899$665.66KForm 4
Aug 18, 2026Sukhatme MayukhPresident & CIOSale31,801$1.18MForm 4
Aug 18, 2026Sukhatme MayukhPresident & CIOOption exercise31,801$122.43KForm 4
Aug 18, 2026Sukhatme MayukhPresident & CIOSale105,141$3.85MForm 4
Aug 18, 2026Sukhatme MayukhPresident & CIOOption exercise105,141$404.79KForm 4
Aug 17, 2026Sukhatme MayukhPresident & CIOSale284,707$10.32MForm 4
Aug 17, 2026Sukhatme MayukhPresident & CIOOption exercise284,707$1.10MForm 4
Aug 14, 2026Sukhatme MayukhPresident & CIOSale243,177$8.81MForm 4
Aug 14, 2026Sukhatme MayukhPresident & CIOOption exercise243,177$936.23KForm 4
Jul 27, 2026Venker EricPresident & Immunovant CEOSale200,000$6.99MForm 4
Jul 27, 2026Venker EricPresident & Immunovant CEOOption exercise200,000$770.00KForm 4
Jul 17, 2026Oren IlanDirectorAward775—Form 4
Jul 17, 2026MOMTAZEE JAMES CDirectorAward405—Form 4
Jul 17, 2026Epperly Melissa B,DirectorAward543—Form 4
Jun 30, 2026Gold Daniel AllenDirectorSale12,380$436.77KForm 4
Jun 30, 2026QVT Financial LPDirector by DeputizationSale12,380$436.77KForm 4
Jun 30, 2026MANCHESTER KEITH SDirectorSale200,000$7.09MForm 4
Jun 30, 2026MANCHESTER KEITH SDirectorSale12,380$436.77KForm 4
Jun 30, 2026Torti FrankPresident and Vant ChairTax withholding40,310$1.43MForm 4
Jun 30, 2026Gline MatthewCEOTax withholding76,171$2.70MForm 4
Jun 30, 2026Sukhatme MayukhPresident & CIOTax withholding46,878$1.66MForm 4
Jun 30, 2026Fitzgerald MeghanDirectorSale10,000$349.00KForm 4
Jun 30, 2026Fitzgerald MeghanDirectorOption exercise10,000$88.00KForm 4
Jun 29, 2026Gold Daniel AllenDirectorSale600,000$20.75MForm 4
Jun 29, 2026Gold Daniel AllenDirectorSale200,000$6.89MForm 4
Jun 29, 2026QVT Financial LPDirector by DeputizationSale600,000$20.75MForm 4
Jun 29, 2026QVT Financial LPDirector by DeputizationSale200,000$6.89MForm 4
Jun 29, 2026MANCHESTER KEITH SDirectorSale600,000$20.75MForm 4
Jun 29, 2026MANCHESTER KEITH SDirectorSale200,000$6.89MForm 4
Jun 29, 2026Epperly Melissa B,DirectorSale2,748$95.38KForm 4
Jun 29, 2026Epperly Melissa B,DirectorSale15,002$514.87KForm 4
Jun 29, 2026Epperly Melissa B,DirectorOption exercise17,750$79.17KForm 4
Jun 26, 2026Sukhatme MayukhPresident & CIOSale500,000$17.04MForm 4
Jun 26, 2026Sukhatme MayukhPresident & CIOOption exercise500,000$1.93MForm 4
Jun 26, 2026Gold Daniel AllenDirectorSale325,000$11.07MForm 4
Jun 26, 2026Gold Daniel AllenDirectorSale300,783$10.20MForm 4
Jun 26, 2026QVT Financial LPDirector by DeputizationSale325,000$11.07MForm 4
Jun 26, 2026QVT Financial LPDirector by DeputizationSale300,783$10.20MForm 4
Jun 26, 2026MANCHESTER KEITH SDirectorSale325,000$11.07MForm 4
Jun 26, 2026MANCHESTER KEITH SDirectorSale300,783$10.20MForm 4
Jun 25, 2026Sukhatme MayukhPresident & CIOSale500,000$17.07MForm 4
Jun 25, 2026Sukhatme MayukhPresident & CIOOption exercise500,000$1.93MForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related